Physician profile
Steven Kang
NPI 1851320162
$431,610.73
in general payments reported to CMS, 2019-2025
21 companies · $41K in 2025
The $41K reported for 2025 was more than what 94% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104K · 2020: $21K · 2021: $42K · 2022: $63K · 2023: $5,350 · 2024: $155K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $153K · Consulting Fee: $20K · Travel and Lodging: $17K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $152,835.00 |
| Consulting Fee | $19,625.00 |
| Travel and Lodging | $16,990.68 |
| Food and Beverage | $11,856.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $264,236.90 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $115,478.27 | 2019-2025 | Watchman Access System, General - Therapies, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24,071.32 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $9,130.65 | 2019 | |
| Irhythm Technologies, INC. | $4,576.27 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $3,461.77 | 2021 | |
| Impulse Dynamics (USA) INC. | $2,789.66 | 2022-2023 | Optimizer |
| Stryker Corporation | $2,051.33 | 2019 | |
| Abbott Laboratories | $1,712.72 | 2020-2025 | Amplatzer Amulet, Ensite, Ensite Precision |
| Biosense Webster, INC. | $1,678.48 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Decanav |
| Medical Device Business Services, INC. | $978.98 | 2019 | |
| Philips North America LLC | $439.03 | 2019-2024 | (9274) Lld |
| Atricure, INC. | $215.62 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $207.19 | 2019 | |
| Silk Road Medical, INC. | $129.13 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $127.32 | 2022 | |
| Aroa Biosurgery Incorporated | $103.40 | 2023-2024 | |
| Biotronik INC. | $98.54 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.80 | 2024 | Jardiance |
| Edwards Lifesciences Corporation | $20.04 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.